LUMOSA THERAPEUTICS CO LTD(TW:6535)
NT$73.50+2.00 (+4.70%)
TW:6535
LUMOSA THERAPEUTICS CO LTD financials statements
NT$73.50
At close:+2.00 (+4.70%)
LUMOSA THERAPEUTICS CO LTD (6535) Ratios
LUMOSA THERAPEUTICS CO LTD Ratios
TW:6535's free cash flow for Q2 2026 was NT$-112.64M. For the 2026 fiscal year, TW:6535's free cash flow was increased by NT$0.00 and operating cash flow was NT$-112.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.37 | 7.64 | 4.75 | 6.44 | 7.23 |
| Quick Ratio | 6.62 | 7.15 | 4.28 | 5.93 | 6.87 |
| Cash Ratio | 1.39 | 1.17 | 1.94 | 2.40 | 3.75 |
| Solvency Ratio | -2.56 | -2.03 | -0.94 | -2.19 | 0.56 |
| Operating Cash Flow Ratio | -2.72 | -1.47 | -1.49 | -1.40 | -2.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 835.06M | NT$ 1.33B | NT$ 816.34M | NT$ 1.17B | NT$ 1.39B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.12 | 1.18 | 1.16 | 1.11 |
| Debt Service Coverage Ratio | -1603.15 | -2290.04 | -4828.21 | -3236.02 | 493.49 |
| Interest Coverage Ratio | -1659.15 | -1908.79 | -7992.02 | -2053.15 | -1654.92 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.05 | 0.08 | 0.03 | 0.08 |
| Net Debt to EBITDA | 0.54 | 0.53 | 1.82 | 1.06 | -6.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.04% | 45.24% | 72.88% | 54.65% | 56.96% |
| EBIT Margin | -930.73% | -1115.21% | -439.31% | -1892.86% | 554.12% |
| EBITDA Margin | -899.31% | -1093.72% | -398.27% | -1809.67% | 739.02% |
| Operating Profit Margin | -930.73% | -911.64% | -659.96% | -1148.26% | -2478.27% |
| Pretax Profit Margin | -967.37% | -1115.69% | -439.39% | -1893.42% | 552.62% |
| Net Profit Margin | -967.37% | -1084.91% | -418.23% | -1856.70% | 552.62% |
| Continuous Operations Profit Margin | -967.37% | -1115.69% | -439.83% | -1893.56% | 552.62% |
| Net Income Per EBT | 100.00% | 97.24% | 95.18% | 98.06% | 100.00% |
| EBT Per EBIT | 103.94% | 122.38% | 66.58% | 164.89% | -22.30% |
| Return on Assets (ROA) | -21.00% | -19.92% | -14.37% | -26.23% | 4.09% |
| Return on Equity (ROE) | -22.96% | -22.22% | -16.99% | -30.35% | 4.53% |
| Return on Capital Employed (ROCE) | -21.95% | -18.48% | -26.14% | -18.31% | -20.25% |
| Return on Invested Capital (ROIC) | -21.85% | -18.44% | -26.06% | -18.27% | -20.20% |
| Return on Tangible Assets | -21.01% | -19.92% | -14.38% | -26.61% | 4.16% |
| Earnings Yield | -1.07% | -1.04% | -2.15% | -7.73% | 1.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.47 | 1.68 | 4.74 | 1.90 | 1.79 |
| Payables Turnover | 10.64 | 15.07 | 10.34 | 12.18 | 0.52 |
| Inventory Turnover | 0.14 | 0.22 | 0.15 | 0.11 | 0.09 |
| Fixed Asset Turnover | 2.48 | 1.99 | 2.07 | 3.48 | 1.34 |
| Asset Turnover | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | 0.03 | 0.04 | 0.06 | 0.02 | 0.01 |
| Cash Conversion Cycle | 2797.17 | 1857.95 | 2498.93 | 3445.35 | 3519.43 |
| Days of Sales Outstanding | 248.39 | 217.64 | 76.97 | 191.78 | 203.75 |
| Days of Inventory Outstanding | 2583.08 | 1664.54 | 2457.26 | 3283.55 | 4023.89 |
| Days of Payables Outstanding | 34.31 | 24.22 | 35.31 | 29.97 | 708.22 |
| Operating Cycle | 2831.48 | 1882.17 | 2534.24 | 3475.32 | 4227.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.15 | -1.81 | -2.03 | -1.85 | -3.00 |
| Free Cash Flow Per Share | -2.15 | -1.82 | -2.12 | -1.86 | -3.01 |
| Dividend Paid and CapEx Coverage Ratio | -533.54 | -658.50 | -21.86 | -131.49 | -785.76 |
| Capital Expenditure Coverage Ratio | -533.54 | -658.50 | -21.86 | -131.49 | -785.76 |
| Operating Cash Flow Coverage Ratio | -51.49 | -34.96 | -26.03 | -64.06 | -39.40 |
| Operating Cash Flow to Sales Ratio | -9.95 | -7.57 | -5.77 | -11.28 | -26.07 |
| Free Cash Flow Yield | -1.11% | -0.73% | -3.10% | -4.73% | -7.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -94.88 | -95.79 | -46.50 | -12.93 | 62.75 |
| Price-to-Sales (P/S) Ratio | 901.73 | 1043.86 | 194.46 | 240.16 | 348.46 |
| Price-to-Book (P/B) Ratio | 21.41 | 21.38 | 7.90 | 3.93 | 2.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -90.48 | -137.72 | -32.25 | -21.13 | -13.35 |
| Price-to-Operating Cash Flow Ratio | -90.65 | -137.93 | -33.72 | -21.30 | -13.37 |
| Price-to-Earnings Growth (PEG) Ratio | 4.42 | -1.24 | 0.90 | 0.02 | -0.51 |
| Enterprise Value Multiple | -99.73 | -94.91 | -47.01 | -12.21 | 40.69 |
| Enterprise Value | 32.14B | 40.64B | 10.66B | 5.89B | 5.22B |
| EV to EBITDA | -99.73 | -94.91 | -47.01 | -12.21 | 40.69 |
| EV to Sales | 896.85 | 1038.06 | 187.21 | 220.94 | 300.72 |
| EV to Free Cash Flow | -90.00 | -136.95 | -31.04 | -19.44 | -11.52 |
| EV to Operating Cash Flow | -90.16 | -137.16 | -32.47 | -19.59 | -11.54 |
| Tangible Book Value Per Share | 9.14 | 11.79 | 8.82 | 10.09 | 13.77 |
| Shareholders’ Equity Per Share | 9.09 | 11.69 | 8.65 | 10.01 | 14.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.22 | 0.24 | 0.35 | 0.16 | 0.12 |
| Net Income Per Share | -2.09 | -2.60 | -1.47 | -3.04 | 0.64 |
| Tax Burden | 1.00 | 0.97 | 0.95 | 0.98 | 1.00 |
| Interest Burden | 1.04 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 8.49 | 8.25 | 6.49 | 10.53 | 23.39 |
| SG&A to Revenue | 1.42 | 1.32 | 0.84 | 1.50 | 1.97 |
| Stock-Based Compensation to Revenue | 0.00 | 0.97 | 0.15 | 0.19 | 0.19 |
| Income Quality | 1.05 | 0.68 | 1.31 | 0.60 | -4.72 |
Currency in TWD
